Ross S. Berkowitz, MD - Obstetrics and Gynecology, Gynecologic OncologyDr. Ross S. Berkowitz reviews medical content for Healthwise, a nonprofit organization with a mission to help people make better health decisions. Dr. Berkowitz is a specialist in gynecologic cancer who has devoted his career to teaching, writing, and editing. He is William H. Baker Professor of Gynecology at Harvard Medical School and Co-Director of the New England Trophoblastic Disease Center. He has been affiliated with Brigham and Women's Hospital in Boston since 1980 and was appointed Director of Gynecology and Gynecologic Oncology in 1989. Education and TrainingMD: Boston University School of Medicine, Boston, MA, 1973 Internship in Surgery: Peter Bent Brigham Hospital, Boston, MA, 1973-1974 Clinical Fellowship in Surgery: Harvard Medical School, Boston, MA, 1973-1975 Residency in Surgery: Peter Bent Brigham Hospital, Boston, MA, 1974-1975 Residency in Obstetrics and Gynecology: Boston Hospital for Women, Boston, MA, 1975-1978 Clinical Fellowship in Obstetrics and Gynecology: Harvard Medical School, Boston, MA, 1975-1978 Clinical Fellowship in Gynecologic Oncology: Boston Hospital for Women, Boston, MA, 1978-1980 Clinical Fellow in Gynecologic Oncology: American Cancer Society, 1978-1980 Junior Faculty Clinical Fellow: American Cancer Society, 1982-1985 CertificationsObstetrics and Gynecology, American Board of Obstetrics and Gynecology Gynecologic Oncology, American Board of Obstetrics and Gynecology Academic AppointmentsHarvard Medical School, Boston, MA: - William H. Baker Professor of Gynecology, 1993-present
- Professor of Obstetrics and Gynecology and Reproductive Biology, 1989-1993
- Associate Professor of Obstetrics and Gynecology, 1984-1989
- Assistant Professor of Obstetrics and Gynecology, Brigham and Women's Hospital, 1980-1984
- Instructor in Obstetrics and Gynecology, The Boston Hospital for Women, 1978-1980
Financial DisclosureThe final approval of Healthwise content is always made by a clinician with no financial conflicts. This reviewer reported no financial conflicts. Current as of:
August 23, 2013 |
|